Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-01-03 @ 1:51 AM
Study NCT ID:
NCT02077634
Status:
COMPLETED
Last Update Posted:
2020-03-18
First Post:
2013-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
Sponsor:
Universität des Saarlandes
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-09
First Submit QC Date:
None
Study First Post Date:
2014-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-17
Last Update Post Date:
2020-03-18
Last Update Post Date Type:
ACTUAL